These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32039368)

  • 1. Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF.
    Blasi A; Patel VC; Adelmeijer J; Azarian S; Aziz F; Fernández J; Bernal W; Lisman T
    JHEP Rep; 2019 Sep; 1(3):179-187. PubMed ID: 32039368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V;
    J Hepatol; 2021 May; 74(5):1097-1108. PubMed ID: 33227350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
    Kerbert AJC; Gupta S; Alabsawy E; Dobler I; Lønsmann I; Hall A; Nielsen SH; Nielsen MJ; Gronbaek H; Amoros À; Yeung D; Macnaughtan J; Mookerjee RP; Macdonald S; Andreola F; Moreau R; Arroyo V; Angeli P; Leeming DJ; Treem W; Karsdal MA; Jalan R
    JHEP Rep; 2021 Dec; 3(6):100355. PubMed ID: 34805815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis.
    López-Vicario C; Checa A; Urdangarin A; Aguilar F; Alcaraz-Quiles J; Caraceni P; Amorós A; Pavesi M; Gómez-Cabrero D; Trebicka J; Oettl K; Moreau R; Planell N; Arroyo V; Wheelock CE; Clària J
    J Hepatol; 2020 Oct; 73(4):817-828. PubMed ID: 32294533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
    Trebicka J; Amoros A; Pitarch C; Titos E; Alcaraz-Quiles J; Schierwagen R; Deulofeu C; Fernandez-Gomez J; Piano S; Caraceni P; Oettl K; Sola E; Laleman W; McNaughtan J; Mookerjee RP; Coenraad MJ; Welzel T; Steib C; Garcia R; Gustot T; Rodriguez Gandia MA; Bañares R; Albillos A; Zeuzem S; Vargas V; Saliba F; Nevens F; Alessandria C; de Gottardi A; Zoller H; Ginès P; Sauerbruch T; Gerbes A; Stauber RE; Bernardi M; Angeli P; Pavesi M; Moreau R; Clària J; Jalan R; Arroyo V
    Front Immunol; 2019; 10():476. PubMed ID: 30941129
    [No Abstract]   [Full Text] [Related]  

  • 6. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
    J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
    Moreau R; Jalan R; Gines P; Pavesi M; Angeli P; Cordoba J; Durand F; Gustot T; Saliba F; Domenicali M; Gerbes A; Wendon J; Alessandria C; Laleman W; Zeuzem S; Trebicka J; Bernardi M; Arroyo V;
    Gastroenterology; 2013 Jun; 144(7):1426-37, 1437.e1-9. PubMed ID: 23474284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
    Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
    J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio.
    Blasi A; Calvo A; Prado V; Reverter E; Reverter JC; Hernández-Tejero M; Aziz F; Amoros A; Cardenas A; Fernández J
    Hepatology; 2018 Dec; 68(6):2325-2337. PubMed ID: 29790188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.
    Clària J; Stauber RE; Coenraad MJ; Moreau R; Jalan R; Pavesi M; Amorós À; Titos E; Alcaraz-Quiles J; Oettl K; Morales-Ruiz M; Angeli P; Domenicali M; Alessandria C; Gerbes A; Wendon J; Nevens F; Trebicka J; Laleman W; Saliba F; Welzel TM; Albillos A; Gustot T; Benten D; Durand F; Ginès P; Bernardi M; Arroyo V;
    Hepatology; 2016 Oct; 64(4):1249-64. PubMed ID: 27483394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation.
    Monteiro S; Grandt J; Uschner FE; Kimer N; Madsen JL; Schierwagen R; Klein S; Welsch C; Schäfer L; Jansen C; Claria J; Alcaraz-Quiles J; Arroyo V; Moreau R; Fernandez J; Bendtsen F; Mehta G; Gluud LL; Møller S; Praktiknjo M; Trebicka J
    Gut; 2021 Feb; 70(2):379-387. PubMed ID: 32241903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis.
    Arroyo V; Moreau R; Jalan R; Ginès P;
    J Hepatol; 2015 Apr; 62(1 Suppl):S131-43. PubMed ID: 25920082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure.
    Blaya D; Pose E; Coll M; Lozano JJ; Graupera I; Schierwagen R; Jansen C; Castro P; Fernandez S; Sidorova J; Vasa-Nicotera M; Solà E; Caballería J; Trebicka J; Ginès P; Sancho-Bru P
    JHEP Rep; 2021 Apr; 3(2):100233. PubMed ID: 33665588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
    J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
    Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
    Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
    J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis.
    Clària J; Curto A; Moreau R; Colsch B; López-Vicario C; Lozano JJ; Aguilar F; Castelli FA; Fenaille F; Junot C; Zhang I; Vinaixa M; Yanes O; Caraceni P; Trebicka J; Fernández J; Angeli P; Jalan R; Arroyo V
    J Hepatol; 2021 Nov; 75(5):1116-1127. PubMed ID: 34245803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
    Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
    Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure.
    Wu W; Sun S; Wang Y; Zhao R; Ren H; Li Z; Zhao H; Zhang Y; Sheng J; Chen Z; Shi Y
    Front Immunol; 2021; 12():620365. PubMed ID: 33717119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute-on-chronic liver failure exists in patients with hepatitis B virus-related decompensated cirrhosis.
    Wang SJ; Yin S; Gu WY; Zhang Y; Li H
    J Dig Dis; 2018 Oct; 19(10):614-625. PubMed ID: 30226019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.